Nathalie Schlienger

Pharmacological and Behavioral Profile of N-(4-Fluorophenylmethyl)-N-(1-methylpiperidin-4-yl)-N′-(4-(2-methylpropyloxy)phenylmethyl) Carbamide (2 R,3 R)-Dihydroxybutanedioate (2:1) (ACP-103), a Novel 5-Hydroxytryptamine2A Receptor Inverse Agonist

Kimberly E. Vanover, David M. Weiner, Malath Makhay et al. · Journal of Pharmacology and Experimental Therapeutics · 2006 · 196 citations · Full text

The Boronic Mannich Reaction in a Solid-Phase Approach

Nathalie Schlienger, Martin R. Bryce, Thomas K. Hansen · Tetrahedron · 2000 · 74 citations

Boronic Mannich Reaction, Boron Nitride, Physics +6

Synthesis, Structure−Activity Relationships, and Characterization of Novel Nonsteroidal and Selective Androgen Receptor Modulators

Nathalie Schlienger, Birgitte W. Lund, Jan Pawlas et al. · Journal of Medicinal Chemistry · 2009 · 43 citations · Full text

Pharmacotherapy, Molecular Pharmacology, Medicinal Chemistry +17

Heterocyclic aldehydes as novel components in the boronic Mannich reaction

Nathalie Schlienger, Martin R. Bryce, Thomas K. Hansen · Tetrahedron Letters · 2000 · 40 citations

Boronic Mannich Reaction, Cross-coupling Reaction, Heterocyclic +5

<i>S</i>-Acyl-2-thioethyl Aryl Phosphotriester Derivatives as Mononucleotide Prodrugs

Nathalie Schlienger, Suzanne Peyrottes, Tarek Kassem et al. · Journal of Medicinal Chemistry · 2000 · 33 citations